SHREE HARI CHEMICALS EXPORT LTD.

Shree Hari Chemicals Export Ltd announced that its Board of Directors has approved the alteration of the Object Clause of the Memorandum of Association (MOA). This significant change, subject to shareholder approval, incorporates new sub-clauses to expand the company's business activities. The amendments include venturing into the trading, manufacturing, and servicing of various types of cranes, lifting equipment, heavy machinery, construction, agricultural, and industrial equipment. Additionally, the company plans to engage in investment activities, including dealing in shares, bonds, and other securities. A further expansion includes undertaking infrastructure projects such as roads, bridges, airports, and renewable energy facilities, along with EPC and PPP arrangements. The board meeting where these approvals were granted commenced at 12:15 p.m. and concluded at 6:00 p.m. on August 25, 2026.

Shree Hari Chemicals Export Ltd's Board of Directors met on August 25, 2026, approving several key resolutions. The company will issue 22,85,000 convertible warrants at ₹176.10 each, totaling ₹40,23,88,500, on a preferential basis, subject to shareholder approval. Additionally, the board approved the re-appointment of Shri Bankesh Chandra Agrawal as Chairman & Managing Director, Shri Sarthak Agarwal and Shri Nihit Agarwal as Whole Time Directors, and Shri Ram Gupta as Independent Director, all for further terms. Shri Amrut Urkude was appointed as an Additional Independent Director. The company also plans to alter its Memorandum of Association and convene its 39th Annual General Meeting on September 24, 2026. Further plans include expansion in dye and chemical units and investment in its subsidiary, Shakambhari Dyechem Private Limited.

Shree Hari Chemicals Export Ltd announced the approval of issuing 22,85,000 convertible warrants to its promoters on a preferential basis. The total issue size aggregates to ₹40,23,88,500, with each warrant priced at ₹176.10. These warrants are convertible into an equal number of equity shares within eighteen months. The issuance is subject to shareholder approval. The company detailed the names of the allottees, including Shri Nihit Agarwal, Smt. Priyamvada Agarwal, Smt. Avanticka Agarwal, and Smt. Smradhi Agarwal, and their expected post-conversion shareholding. A minimum of 25% of the issue price is payable at subscription, with the balance due before conversion.

Shree Hari Chemicals Export Ltd's Board of Directors, in a meeting held on August 25, 2026, approved several key appointments and re-appointments. Shri Bankesh Chandra Agrawal was re-appointed as Chairman & Managing Director for three years. Shri Sarthak Agarwal and Shri Nihit Agarwal were re-appointed as Whole Time Directors for three years each. Mr. Shri Ram Gupta was re-appointed as Independent Director for a second five-year term. Additionally, Shri Amrut Urkude was appointed as an Additional Independent Director for five years. All appointments are subject to shareholder approval. The board meeting lasted from 12:15 p.m. to 6:00 p.m.

Shree Hari Chemicals Export Ltd has announced a closure of its trading window from August 19, 2026, until 48 hours after a board meeting scheduled for August 25, 2026. The board meeting will consider and approve the issuance of warrants on a preferential basis and the convening of the 39th Annual General Meeting. This move is in compliance with SEBI regulations and the company's internal code of conduct for insider trading. The trading window will reopen on August 27, 2026, after the board meeting where the preferential issue will be discussed.

Shree Hari Chemicals Export Ltd has announced a Board of Directors meeting scheduled for August 25, 2026. The primary agenda items include the consideration and approval of issuing warrants on a preferential basis. Additionally, the board will discuss convening the 39th Annual General Meeting, where the fund-raising through warrant issuance will be presented for approval. In line with SEBI regulations and the company's internal code of conduct, the trading window for the company's securities will be closed from August 19, 2026, until 48 hours after the board meeting concludes, i.e., August 27, 2026. This closure prohibits trading by directors, officers, designated employees, and their related parties.

Shree Hari Chemicals Export Ltd has filed a statement confirming NIL deviation or variation in the utilization of proceeds from its Preferential Issue for the quarter ended June 30, 2026. The company stated that the funds raised, amounting to ₹14,74,59,820, have been fully utilized as per the original objects disclosed. This filing is in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The statement confirms no changes in the use of funds from what was approved by shareholders.

Shree Hari Chemicals Export Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved these standalone and consolidated results during a meeting held on August 14, 2026. The company submitted the results along with the Limited Review Report from its auditors, Kailash Chand Jain & Co. The results were prepared in accordance with Indian Accounting Standard 34 (Ind AS-34) and other accepted accounting principles. The review was conducted as per Standard on Review Engagements (SRE) 2410, providing moderate assurance.

Shree Hari Chemicals Export Ltd announced its un-audited financial results for the quarter ended June 30, 2026. The Board of Directors approved both standalone and consolidated results. The company also submitted a statement on the utilization of preferential issue proceeds, indicating nil deviation. The meeting was held on August 14, 2026.

Shree Hari Chemicals Export Ltd has responded to a BSE query regarding unusual price movements in its securities. The company stated that there are no undisclosed events or information that could impact its operations or financial performance, including any price-sensitive information. This clarification aims to address market speculation and maintain transparency with investors.